340B Orphan Drug Rule Vacated, Discount Exemption Applies To All Uses
This article was originally published in The Pink Sheet Daily
Executive Summary
The Pharmaceutical Research and Manufacturers of America wins its challenge to the government's interpretation of the statutory ban on 340B discounts for orphan drugs.